Drug-related hazardous conditions to prevent injury and defining injury is also important

Authors

  • Sandra L. Kane-Gill,

    Corresponding author
    1. Associate Professor of Pharmacy and Therapeutics, and Clinical Translational Science Institute, Center for Pharmacoinformatics and Outcomes Research, Pittsburgh, PA, USA
    • Critical Care Medication Safety Officer, Department of Pharmacy, UPMC, Pittsburgh, PA, USA
    Search for more papers by this author
  • Tiffany R. Chapman,

    1. Safe Medication Use Resident, Department of Pharmacy, UPMC, Pittsburgh, PA, USA
    Search for more papers by this author
  • Joseph F. Dasta

    1. Professor Emeritus, The Ohio State University, College of Pharmacy, Columbus, OH, USA
    2. Adjunct Professor, University of Texas, College of Pharmacy, Texas, USA
    Search for more papers by this author

S. L. Kane-Gill, Associate Professor of Pharmacy and Therapeutics, and Clinical Translational Science Institute, Center for Pharmacoinformatics and Outcomes Research, 918 Salk Hall, 3501 Terrace St. Pittsburgh, PA 15261, USA.

E-mail: SLK54@pitt.edu

No abstract is available for this article.

Ancillary